We have moved to a new site

We are now located 100 yards up the road next to Pleck Health Centre

14 Oxford Street,
Walsall,
West Midlands,
WS2 9HY
Ok
pleck pharmacy logo
We use cookies to enhance your browsing experience. By clicking 'I Understand and Accept', you consent to our use of cookies.
I understand and accept
No, I don't want to use cookies
My Account
Control Panel
An example toast message
Do Something
Login
en
en
pleck pharmacy logopleck pharmacy logo
Menu
en
en
Change Language
Login
My Account
Control Panel
Home
Pharmacy First
Pharmacy Services
Contact Us
Health Advice
Order
Log Out
Login
Login
en
en
Do Something
Login
en
en
pleck pharmacy logopleck pharmacy logo
Menu
en
en
Change Language
Login
My Account
Control Panel
Home
Pharmacy First
Pharmacy Services
Contact Us
Health Advice
Order
Log Out
Login
Login
en
en
PSA testing

There's currently no screening programme for prostate cancer in the UK. This is because it has not been proved that the benefits would outweigh the risks.

PSA screening

Routinely screening all men to check their prostate-specific antigen (PSA) levels is a controversial subject in the international medical community. There are several reasons for this.

PSA tests are unreliable and can suggest prostate cancer when no cancer exists (a false-positive result). Most men are now offered an MRI scan before a biopsy to help avoid unnecessary tests, but some men may have invasive, and sometimes painful, biopsies for no reason.

Furthermore, around 1 in 7 of those with normal PSA levels may have prostate cancer (a false-negative result), so many cases may be missed.

The PSA test can find aggressive prostate cancer that needs treatment, but it can also find slow-growing cancer that may never cause symptoms or shorten life. Some men may face difficult decisions about treatment, although this is less likely now that most men are offered an MRI scan before further tests and treatment

Treating prostate cancer in its early stages can be beneficial in some cases, but the side effects of the various treatments are potentially so serious that men may choose to delay treatment until it's absolutely necessary.

Although screening has been shown to reduce a man's chance of dying from prostate cancer, it would mean many men receive treatment unnecessarily.

More research is needed to determine whether the possible benefits of a screening programme would outweigh the harms of:

  • overdiagnosis – people being diagnosed with a cancer that would never cause symptoms or shorten life expectancy
  • overtreatment – people being treated unnecessarily for tumours that would unlikely be harmful
Should you know your PSA level?

Instead of a national screening programme, there is an informed choice programme, called prostate cancer risk management, for healthy men aged 50 or over who ask their GP about PSA testing. It aims to give men good information on the pros and cons of a PSA test.

If you're aged 50 or over and decide to have your PSA levels tested after talking to a GP, they can arrange for it to be carried out free on the NHS.

If results show you have a raised level of PSA, the GP may suggest further tests.

Further information

Last Reviewed
20 December 2023
NHS websiteNHS website
pleck pharmacy logo
14 Oxford Street,
Walsall,
West Midlands,
WS2 9HY
Company Registration: 07893857
Premises GPhC Number: 1038515
Superintendant: Bilal Shah (2061734)
Menu
Pharmacy First
All Pharmacy First Services
Earache
Impetigo
Insect Bite
Shingles
Sinusitis
Sore Throat
Urinary Tract Infections (UTIs)
Home
Pharmacy Services
Contact Us
Order Prescriptions
Health Advice
Useful Links
NHS Choices
Patient UK
Fit For Travel
Opening Hours
Store Hours Unavailable
No store selected for opening hours
Loading Open Hours...
Pleck Pharmacy © 2024
Privacy Policy